Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.
作者信息
Kalogeropoulos Andreas P, Georgiopoulou Vasiliki V, Borlaug Barry A, Gheorghiade Mihai, Butler Javed
机构信息
Division of Cardiology, Emory University, Atlanta, GA, USA.
出版信息
Circ Heart Fail. 2013 May;6(3):584-93. doi: 10.1161/CIRCHEARTFAILURE.112.000096.
Abstract
摘要
相似文献
1
Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.
Circ Heart Fail. 2013 May;6(3):584-93. doi: 10.1161/CIRCHEARTFAILURE.112.000096.
2
Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
J Am Coll Cardiol. 1996 Dec;28(7):1775-80. doi: 10.1016/S0735-1097(96)00399-3.
3
Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension.
ASAIO J. 2005 Jul-Aug;51(4):456-60. doi: 10.1097/01.mat.0000169125.21268.d7.
4
Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.
J Am Heart Assoc. 2019 Aug 20;8(16):e012073. doi: 10.1161/JAHA.119.012073. Epub 2019 Aug 14.
5
Determinants and prognostic implications of the negative diastolic pulmonary pressure gradient in patients with pulmonary hypertension due to left heart disease.
Eur J Heart Fail. 2017 Jan;19(1):88-97. doi: 10.1002/ejhf.675. Epub 2016 Oct 17.
6
Acute left ventricular failure after bilateral lung transplantation for idiopathic pulmonary arterial hypertension.
J Thorac Cardiovasc Surg. 2013 Jan;145(1):e7-9. doi: 10.1016/j.jtcvs.2012.10.020. Epub 2012 Nov 8.
7
Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy.
JACC Heart Fail. 2014 Jun;2(3):230-7. doi: 10.1016/j.jchf.2014.02.004. Epub 2014 Apr 30.
8
Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.
Circ Heart Fail. 2018 Apr;11(4):e004436. doi: 10.1161/CIRCHEARTFAILURE.117.004436.
9
Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
Am Heart J. 2003 Feb;145(2):310-6. doi: 10.1067/mhj.2003.146.
10
Sildenafil in heart transplant candidates with pulmonary hypertension.
Arch Cardiovasc Dis. 2015 Jun-Jul;108(6-7):375-84. doi: 10.1016/j.acvd.2015.01.013. Epub 2015 Apr 25.
引用本文的文献
1
Can Right Heart Catheterization Improve the Prediction of Positive Response to Resynchronization Therapy?
Biomedicines. 2025 Feb 14;13(2):467. doi: 10.3390/biomedicines13020467.
2
Ventricular Function and Cardio-Ankle Vascular Index in Patients With Pulmonary Artery Hypertension.
Vasc Health Risk Manag. 2022 Dec 28;18:889-904. doi: 10.2147/VHRM.S385536. eCollection 2022.
3
Improvement of Left Ventricular Ejection Fraction and Pulmonary Hypertension Are Significant Prognostic Factors in Heart Failure with Reduced Ejection Fraction Patients.
J Cardiovasc Imaging. 2019 Oct;27(4):257-265. doi: 10.4250/jcvi.2019.27.e36.
4
Use of Cardiac Imaging to Evaluate Cardiac Function and Pulmonary Hemodynamics in Patients with Heart Failure.
Curr Cardiol Rep. 2019 May 10;21(6):53. doi: 10.1007/s11886-019-1138-4.
5
Hemodynamics of the diastolic pressure gradients in acute heart failure: implications for the diagnosis of pre-capillary pulmonary hypertension in left heart disease.
Pulm Circ. 2019 Jan-Mar;9(1):2045894018815438. doi: 10.1177/2045894018815438. Epub 2018 Nov 13.
6
Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction.
J Am Heart Assoc. 2016 Jan 25;5(1):e002477. doi: 10.1161/JAHA.115.002477.
7
Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients.
J Am Heart Assoc. 2014 Feb 3;3(1):e000363. doi: 10.1161/JAHA.113.000363.
本文引用的文献
1
Late-Breaking Clinical Trial Abstracts.
Circulation. 2015 Dec 8;132(23):2267-85. doi: 10.1161/CIR.0000000000000334.
2
Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation.
J Heart Lung Transplant. 2012 Dec;31(12):1281-7. doi: 10.1016/j.healun.2012.09.009. Epub 2012 Nov 3.
3
The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study.
Int J Cardiol. 2013 Sep 20;168(1):60-5. doi: 10.1016/j.ijcard.2012.09.074. Epub 2012 Oct 8.
4
PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design.
Circ Heart Fail. 2012 Sep 1;5(5):653-9. doi: 10.1161/CIRCHEARTFAILURE.112.969071.
5
World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation.
J Heart Lung Transplant. 2012 Sep;31(9):913-33. doi: 10.1016/j.healun.2012.06.002.
6
Clinical adoption of prognostic biomarkers: the case for heart failure.
Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):3-13. doi: 10.1016/j.pcad.2012.05.004.
7
Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials.
Curr Heart Fail Rep. 2012 Sep;9(3):192-9. doi: 10.1007/s11897-012-0101-0.
8
Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and design.
Eur J Heart Fail. 2012 Aug;14(8):946-53. doi: 10.1093/eurjhf/hfs071. Epub 2012 Jun 20.
9
Soluble guanylate cyclase: a potential therapeutic target for heart failure.
Heart Fail Rev. 2013 Mar;18(2):123-34. doi: 10.1007/s10741-012-9323-1.
10
Pulmonary artery hypertension in heart transplant recipients: how much is too much?
Eur J Cardiothorac Surg. 2012 Nov;42(5):864-9; discussion 869-70. doi: 10.1093/ejcts/ezs102. Epub 2012 Mar 7.
Zotero 插件